Trial Profile
Exploratory Study to Compare Mechanical Penetration Enhancers on Metvixia Skin Penetration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Acne; Actinic keratosis; Basal cell cancer; Squamous cell cancer
- Focus Pharmacokinetics
- Sponsors Galderma
- 31 Jul 2015 New trial record